Crossmark

Does dexamethasone implant combination with aflibercept monotherapy affect one-year outcomes in treatment-naive diabetic macular edema with inflammatory biomarkers?

Crossref DOI link: https://doi.org/10.1007/s10792-024-02963-8

Published Online: 2024-02-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ozsaygılı, Cemal https://orcid.org/0000-0002-8236-1728
Bayram, Nurettin https://orcid.org/0000-0003-3244-7328
License Information

Text and Data Mining valid from 2024-02-09

Version of Record valid from 2024-02-09
More Information

Article History

Received: 28 September 2023

Accepted: 4 December 2023

First Online: 9 February 2024

Declarations

:

: The authors report no conflicts of interest. The authors are responsible for the content and writing of the paper.

Document is current

Any future updates will be listed below